找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Liver Radioembolization with 90Y Microspheres; José Ignacio Bilbao,Maximilian F Reiser Book 2014Latest edition Springer-Verlag Berlin Heid

[復(fù)制鏈接]
樓主: 吞食
51#
發(fā)表于 2025-3-30 11:28:47 | 只看該作者
Treatment of Neuroendocrine Tumors with Selective Internal Radiation Therapy,zed. While ablative therapies can treat one lesion at a time, most patients benefit from having a regional approach to their treatment. Use of .Yttrium beads has been demonstrated to not only be safe and effective but also to permit significant quality of life since the treatments are performed on an outpatient basis.
52#
發(fā)表于 2025-3-30 14:36:23 | 只看該作者
Yttrium-90 Microspheres for Other Liver Metastases,IR-Spheres to produce significant rates of tumor growth control among patients with either hepatocarcinoma or liver metastases from colorectal cancer and neuroendocrine tumors. In the present chapter current data regarding the role of this approach in the management of liver metastases from other tumor types are provided.
53#
發(fā)表于 2025-3-30 18:02:42 | 只看該作者
Radioembolization-Induced Liver Disease,embolization. Its incidence is likely to be lower than 10?% and it has a transient or stable course in most cases, but it may unusually lead to overt liver failure. A conservative dose prescription and the use of low-dose steroids or ursodeoxycholic acid have been suggested as prophylactic measures.
54#
發(fā)表于 2025-3-31 00:30:13 | 只看該作者
0942-5373 in clinical practice.Detailed information on candidate selec.This is the second edition of a very well received book devoted specifically to the treatment of liver tumors by radioembolization with .90.Y microspheres. The success of the first edition was based on the provision of all the fundamental
55#
發(fā)表于 2025-3-31 01:10:18 | 只看該作者
HCC. Radioembolization Combined with Other Therapeutic Local and Systemic Treatment,st not meeting the criteria for resection, percutaneous ablation or transplantation by downsizing/downgrading or in progressed disease where transarterial chemotherapy is contraindicated. Recent results of radio embolization in these settings and future directions will be discussed.
56#
發(fā)表于 2025-3-31 05:30:18 | 只看該作者
Radiological Evaluation of Patients with Liver Tumors,d the clinical background, several modalities can be selected for imaging patients with liver tumors. These imaging modalities will be described in this chapter and their respective advantages and limitations will be analyzed.
57#
發(fā)表于 2025-3-31 13:07:32 | 只看該作者
Principles for Combining Radioembolisation with Systemic Chemotherapy for Metastatic Colorectal Canhemotherapy have shown promising results in patients with metastatic colorectal cancer. In this chapter, the scientific rationale for combining RE with chemotherapy is outlined and the evidence base for combining RE with systemic chemotherapy in the treatment of metastatic colorectal cancer is appraised.
58#
發(fā)表于 2025-3-31 17:02:21 | 只看該作者
59#
發(fā)表于 2025-3-31 18:41:29 | 只看該作者
Surgical Treatment and Radioembolization,red to other transarterial treatments, and it could be effective not only in hepatocellular carcinoma but also in selected patients with liver metastases. Since these metastases are usually unresectable at initial diagnosis, this treatment has been increasingly used in salvage setting for these patients.
60#
發(fā)表于 2025-3-31 23:54:33 | 只看該作者
Complications and Side Effects,aken in order to understand the angiographic, technical, and safety aspects concerning liver radioembolization. The most common complications of radioembolization include non-target radiation (pancreatitis, GI ulcers, cholecystitis), radiation pneumonitis, radiation-induced liver disease (radiation hepatitis), and biliary complications.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 06:16
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
元阳县| 乐陵市| 洛川县| 绥江县| 凤台县| 新河县| 大安市| 兴城市| 孟州市| 潍坊市| 沁源县| 锡林浩特市| 东至县| 隆安县| 肇东市| 通化县| 辽宁省| 开封县| 保靖县| 阿尔山市| 寻乌县| 台南市| 湄潭县| 赣榆县| 涞源县| 克什克腾旗| 兰西县| 木里| 抚州市| 遵化市| 枝江市| 泽州县| 双桥区| 兴文县| 会泽县| 公安县| 五指山市| 波密县| 马边| 两当县| 鄂尔多斯市|